Conferences

ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

18th International Meeting of the European Society of Gynaecological Oncology (ESGO)

19 - 22 Oct 2013
Liverpool, United Kingdom
Follow up study on the effect of chemotherapy in pregnant women
Prof Fredric Amant - University of Leuven, Belgium
Follow up study on the effect of chemotherapy in pregnant women ( Prof Fredric Amant - University of Leuven, Belgium )
1 Nov 2013
Results from the TRINOVA 1 trial
Prof Bradley Monk - Creighton University School of Medicine, USA
Results from the TRINOVA 1 trial ( Prof Bradley Monk - Creighton University School of Medicine, USA )
1 Nov 2013
Clinical trials, ENGOT and use of bevacizumab against angiogenesis
Prof Christian Marth - Innsbruck Medical University, Austria
Clinical trials, ENGOT and use of bevacizumab against angiogenesis ( Prof Christian Marth - Innsbruck Medical University, Austria )
1 Nov 2013
Emerging sentinel node in cervical cancer
Prof David Cibula - Charles University Hospital, Prague, Czech Republic
Emerging sentinel node in cervical cancer ( Prof David Cibula - Charles University Hospital, Prague, Czech Republic )
1 Nov 2013
Emotional and physical effects of cancer in life after treatment
Prof Annette Hasenburg - Universitätsklinikum Freiburg, Germany
Emotional and physical effects of cancer in life after treatment ( Prof Annette Hasenburg - Universitätsklinikum Freiburg, Germany )
1 Nov 2013
Selecting treatment methods for cervical cancer
Prof Denis Querleu - Claudius Regaud Cancer Center and University of Toulouse, F...
Selecting treatment methods for cervical cancer ( Prof Denis Querleu - Claudius Regaud Cancer Center and University of Toulouse, France )
1 Nov 2013
Results of the ICON7, phase III clinical trial
Prof Eric Pujade-Lauraine - Université de Paris Descartes, France
Results of the ICON7, phase III clinical trial ( Prof Eric Pujade-Lauraine - Université de Paris Descartes, France )
1 Nov 2013
Overview of the 2013 ESGO scientific programme
Prof John Green – University of Liverpool, UK
Overview of the 2013 ESGO scientific programme ( Prof John Green – University of Liverpool, UK )
31 Oct 2013
Treatment guidelines for endometrial cancer and increased rates of incidence
Prof John Green - University of Liverpool, UK
Treatment guidelines for endometrial cancer and increased rates of incidence ( Prof John Green - University of Liverpool, UK )
31 Oct 2013
Understanding the causes of endometrial cancer
Prof Martin Widschwendter - University College London Hospital, UK
Understanding the causes of endometrial cancer ( Prof Martin Widschwendter - University College London Hospital, UK )
31 Oct 2013
Disparities in ovarian and cervical cancer screening across Europe
Prof Vesna Kesic - ESGO President Elect
Disparities in ovarian and cervical cancer screening across Europe ( Prof Vesna Kesic - ESGO President Elect )
31 Oct 2013
ESGO president-elect discusses the future goals of the society
Prof Vesna Kesnic - ESGO President Elect
ESGO president-elect discusses the future goals of the society ( Prof Vesna Kesnic - ESGO President Elect )
31 Oct 2013
Fertility preserving surgical treatment methods in young women
Dr Dominik Denschlag - Hoch-Taunus-Hospitals, Germany
Fertility preserving surgical treatment methods in young women ( Dr Dominik Denschlag - Hoch-Taunus-Hospitals, Germany )
31 Oct 2013
Pathologic Ultra Staging in endometrial cancer
Dr Nadeem Abu Rustum - Memorial Sloan Kettering Cancer Center, New York, USA
Pathologic Ultra Staging in endometrial cancer ( Dr Nadeem Abu Rustum - Memorial Sloan Kettering Cancer Center, New York, USA )
31 Oct 2013
HPV testing and genotyping in primary screening in developed countries
Dr Mario Sideri
HPV testing and genotyping in primary screening in developed countries ( Dr Mario Sideri )
31 Oct 2013
End of life care in gynaecological cancer
Dr Johan Menten - University of Lueven, Belgium
End of life care in gynaecological cancer ( Dr Johan Menten - University of Lueven, Belgium )
31 Oct 2013
Molecular profiling of primary compared to metastatic lesion in gynaecologic can...
Prof Helga Birgitte Salvesen - University of Bergen, Norway
Molecular profiling of primary compared to metastatic lesion in gynaecologic cancers ( Prof Helga Birgitte Salvesen - University of Bergen, Norway )
31 Oct 2013
Outcomes of early stage ovarian endometrioid carcinoma
Dr Aalok Kumar - Medical Oncology, British Columbia Cancer Agency, Vancouver, Ca...
Outcomes of early stage ovarian endometrioid carcinoma ( Dr Aalok Kumar - Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada )
1 Oct 2013